Research programme: women's health therapeutics - Avion PharmaceuticalsAlternative Names: Captisol®-enabled therapeutics - Avion Pharmaceuticals; Cyclodextrin-enabled therapeutics - Avion Pharmaceuticals
Latest Information Update: 22 Aug 2014
At a glance
- Originator Avion Pharmaceuticals
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Female genital diseases
Most Recent Events
- 15 Aug 2014 Early research in Gynaecological disorders in USA (PO)
- 15 Aug 2014 Early research in Gynaecological disorders in USA (Topical)